This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. This document includes guidance on an important additional option for cervical screening, the use of mRNA (messenger RNA) HPV testing. This gives countries a...
The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....
The objectives of these guidelines are:
• to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and
• to support countries to update their national guidelines for the use of thermal ablation for cervical precancer.
These guidelines were developed using the W...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytology, c...
